Body Protective Compound 157 + Palivizumab
Palivizumab brand name: Synagis.
We found no known interaction between Body Protective Compound 157 and Palivizumab in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.
Body Protective Compound 157 and Palivizumab
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Palivizumab and Body Protective Compound 157 in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
Worth understanding: our licensed dataset holds no drug-interaction record for Body Protective Compound 157 at all — not against Palivizumab, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.
If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Body Protective Compound 157 safety at a glance
Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
See Every Supplement That Interacts With Palivizumab
This page covers Body Protective Compound 157 only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Palivizumab page lists 53 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).
By severity: 52 moderate · 1 minor.
From our pharmacist’s overview on the Palivizumab page
“Everything on this list for palivizumab (Synagis), the antibody injection given monthly to shield premature and other high-risk infants from RSV, points in one direction. These are supplements that stimulate the immune system, and stimulating the immune system could in theory work against a medicine that acts on it.”
Reviewed by 2 · Jul 18, 2026
Where Body Protective Compound 157 and Palivizumab Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#1,327 of 1,452 supplements looked up here in the last 7 days
#1,770 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Body Protective Compound 157 is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Body Protective Compound 157 reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Body Protective Compound 157 and Palivizumab records this page draws on were last updated June 20, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Body Protective Compound 157
What is Body Protective Compound 157?
- Tendon, ligament, and muscle injuries
- Joint pain and recovery from sports injuries
- Gut healing and inflammation
- Wound healing
- General tissue repair and recovery
BPC 157 is a synthetic peptide that has shown promising healing effects in animal and laboratory studies, but it has not been proven safe or effective in well-designed human trials. It is not an approved drug or a legal dietary supplement in many places, so we cannot recommend it; talk to your doctor or pharmacist before considering it.
Synthetic peptide (a lab-made chain of 15 amino acids based on a sequence found in human gastric juice) · Injectable solution, oral capsules, nasal sprays, and topical preparations sold as research chemicals or compounded products
An interaction check asks whether these two react with each other — it does not ask whether Body Protective Compound 157 is a good idea for someone in your situation. Here is what our Body Protective Compound 157 record says about it on its own.
Body Protective Compound 157: dosing
There is no established, scientifically validated dose for BPC 157 in humans. Because it has not gone through proper clinical testing, no health authority has set a safe or effective amount.Doses suggested on websites and forums are not backed by solid human research, and we will not list specific amounts because doing so could imply they are safe or proven.
From our Body Protective Compound 157 monograph — the full record covers uses, side effects and every documented interaction.
About Palivizumab Injection
What Is Palivizumab Injection Used For?
Brand name: Synagis
Synagis (palivizumab) is used to prevent serious lower respiratory tract disease caused by RSV — not to treat an infection that has already started. It is given to high-risk babies and young children before and during RSV season.
Synagis is approved for infants born at 35 weeks gestation or earlier who are 6 months old or younger at the start of RSV season; children up to 24 months old with bronchopulmonary dysplasia (BPD, a chronic lung condition) who needed medical treatment in the past 6 months; and children up to 24 months old with hemodynamically significant congenital heart disease (a heart defect that affects blood flow).
Other Drugs & Body Protective Compound 157
Browse every other medication we’ve checked against Body Protective Compound 157 — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
No interaction 2,829 drugs checked — show the list
We also checked Body Protective Compound 157 against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Metoprolol ›
- Aspirin ›
- Ivermectin ›
- Rivaroxaban ›
- Rosuvastatin ›
- Escitalopram ›
- Acetaminophen ›
- Tadalafil ›
- Clopidogrel ›
- Atorvastatin ›
- Docusate ›
- Abemaciclib ›
- Hydroxyurea ›
- Valacyclovir ›
- Methamphetamine ›
- Ibuprofen ›
- Semaglutide ›
- Sumatriptan ›
- Warfarin Sodium ›
- Tirzepatide ›
- Prednisone ›
- Propranolol ›
- Bupropion ›
- Lisdexamfetamine ›
- Metformin ›
- Amoxicillin ›
- Lisinopril ›
- Bendamustine ›
- Acyclovir ›
- Amitriptyline ›
- Doxycycline ›
- Methotrexate ›
- Lamotrigine ›
- Fluoxetine ›
- Amphetamine ›
- Acetaminophen, Codeine ›
- Pregabalin ›
- Gabapentin ›
- Dextroamphetamine ›
- Azithromycin ›
- Isotretinoin ›
- Methylene Blue ›
- Clonazepam ›
- Omeprazole ›
- Quetiapine ›
- Amlodipine Besylate ›
- Duloxetine ›
- Letrozole ›
- Buspirone ›
- Naproxen ›
- Citalopram ›
- Ciprofloxacin ›
Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Body Protective Compound 157 list.
Body Protective Compound 157 References
The 1 sources that drive our Body Protective Compound 157 monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Body Protective Compound 157 is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.
- Dietary Supplements: What You Need to Know — NIH Office of Dietary Supplements Source
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Taking Body Protective Compound 157 and Palivizumab Together: Common Questions
Is it safe to take Body Protective Compound 157 with Palivizumab?
Does Palivizumab interact with any supplements?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Palivizumab and Body Protective Compound 157?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.